1. P871: ISB 1442, A FIRST-IN-CLASS CD38 AND CD47 BISPECIFIC ANTIBODY INNATE CELL MODULATOR FOR THE TREATMENT OF CD38 POSITIVE HEMATOLOGICAL MALIGNANCIES. (23rd June 2022) Authors: Grandclement, C.; Estoppey, C.; Dheilly, E.; Panagopoulou, M.; Martini, E.; Labanca, V.; De Angelis, S.; Frei, J.; Drake, A.; Rubod, A.; Gudi, G.; Udupa, V.; Koch Olsen, J.; Giovannini, R.; Doucey, M. A.; Feldman, E.; Konto, C.; Srivastava, A.; Perro, M.; Sammicheli, S. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 764 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. THU0035 OX40L EXPRESSING NEUTROPHILS INDUCE CD4 T FOLLICULAR AND PERIPHERAL HELPER CELL DIFFERENTIATION IN SYSTEMIC LUPUS ERYTHEMATOSUS. (2nd June 2020) Authors: Pappalardo, A.; Wojciechowski, E.; Odriozola, I.; Douchet, I.; Merillon, N.; Boizard-Moracchini, A.; Duffau, P.; Lazaro, E.; Doucey, M. A.; Mbow, L.; Richez, C.; Blanco, P. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 230 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗